Moreover, patients with S100B level ≥4 μg/L were usually accompanied by serious hemorrhagic brain injury, yet ones with S100B level <4 μg/L were prone to suffer from diffusive embolic cerebral infarction (Korfias et al., 2007). This evidence concerns the gene S100B and brain injury.